Micillo, M., Pirajno, B., Montalbano, M. C., Giuffrè, G., Vallone, F., Omezzolli, G., Fascì, A., Nabelsi, N., Navarro-Tableros, V., Bolli, E., Mouhssine, S., Moia, R., Vitale, C., Gaidano, G., Lannutti, B., Jessen, K., Vaisitti, T., Deaglio, S. (2025). Targeting a novel surface antigen, ryk, with the antibody-drug conjugate, slv-404, is effective in richter transformation patient-derived xenografts. Blood. https://doi.org/10.1182/blood-2025-7063